NVAX - Trade Savi - 360-degree view on crypto market

NOVOb NVAX

Novavax sells Czech facility to Novo Nordisk for $200 million

Novavax sells its Czech manufacturing plant to Novo Nordisk for $200 million to support vaccine development and streamline operations, reducing annual expenses by $80 million.

investing.com • 04/12/2024 - 11:50 AM

NVAX NVO

Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mln

Novavax sells its Czech manufacturing facility to Novo Nordisk for $200 million, streamlining operations and saving approximately $80 million annually.

investing.com • 04/12/2024 - 10:08 AM

MRNA NVAX NVO PFE SNY

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million

Novavax sells its Czech manufacturing facility to Novo Nordisk for $200 million to boost its vaccine pipeline and reduce costs, amid struggles with COVID-19 vaccine competition.

investing.com • 04/12/2024 - 08:03 AM

AAPL AMAT BABA BNTX BRKa DPZ MRNA NVAX PLTR POOL TSLA

Apple, Moderna, Applied Materials fall premarket; Alibaba, Domino's Pizza rise

US stock futures decline as post-election rally fades; key movers include Apple down 0.7%, Tesla up 0.7%, and Applied Materials down 8.2%.

investing.com • 15/11/2024 - 12:40 PM

BAVA CAG CCEP CHD CL GIS KDP KHC LLY MNST MRNA NVAX NVO PEP PFE PG RHHBY SNY

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

U.S. drugmaker shares fell after Trump appointed Robert F. Kennedy Jr. to lead health, raising investor concerns over vaccine policies and agency oversight.

investing.com • 15/11/2024 - 11:55 AM

1YMZ24 AAPL BNTX ESZ24 GOOGL MRNA NQZ24 NVAX NVDA PFE RTYZ24

Futures drop as Powell signals no hurry on rate cuts

U.S. stock futures decrease after Powell notes no urgent rate cuts needed. Bond yields rise, impacting equities. Vaccine stocks suffer amid new Health Secretary's appointment. Economic data ahead.

investing.com • 15/11/2024 - 10:58 AM

NVAX

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Novavax reduced its revenue forecast due to disappointing COVID vaccine sales, anticipating lower earnings as it prepares to transfer sales rights to Sanofi.

investing.com • 12/11/2024 - 13:05 PM

MRNA NVAX PFE

Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot

The FDA has lifted its hold on Novavax's COVID-influenza vaccine trials, following clarifications that symptoms reported by a participant were linked to ALS, not the vaccine.

investing.com • 11/11/2024 - 13:57 PM

NVAX

Novavax gets EU authorization for updated COVID vaccine targeting JN.1 strain

The European Commission authorized Novavax's updated COVID-19 vaccine for individuals 12 and older, targeting the JN.1 strain and offering a traditional protein-based alternative.

investing.com • 09/10/2024 - 11:32 AM

NVAX

FDA authorizes Novavax's updated COVID vaccine targeting JN.1 strain

The FDA has granted emergency use authorization for Novavax's updated COVID vaccine targeting the JN.1 strain, providing an additional option as demand remains low.

investing.com • 30/08/2024 - 18:44 PM

Greed and Fear Index

Currency